DELEK GROUP (DLEKG) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
31 Aug, 2026Executive summary
Achieved strong growth in net profit, reaching approximately ₪3.26 billion for 2025, with continued expansion across core business segments.
Completed major strategic transactions, including a new export agreement to Egypt, expansion in the North Sea, and acquisition of control in Isracard.
Distributed significant dividends to shareholders, totaling about ₪1.035 billion, with a dividend yield of 8%.
Financial highlights
Total revenues for 2025 reached ₪16.1 billion, up from ₪11.96 billion in 2024.
Net profit attributable to shareholders was ₪3.26 billion, with adjusted net profit of ₪305 million after excluding one-time items.
Equity as of December 31, 2025, stood at over ₪10 billion, and net financial debt was ₪3.8 billion.
Subsidiaries distributed dividends totaling ₪2.6 billion, with the group’s share at ₪1.37 billion.
Outlook and guidance
Increased production capacity at Leviathan field to 14 BCM/year, with investment decision to expand to 21 BCM (Leviathan B project).
Ongoing focus on operational efficiency, expansion in energy and financial services, and continued dividend distributions.
Latest events from DELEK GROUP
- Record growth in revenue, profit, and dividends, with strong production and improved leverage.DLEKG
Q2 2026 - Q1 2026 delivered robust revenue and profit growth, lower leverage, and high dividend yield.DLEKG
Q1 2026 - Q3 2025 net income surged on Ithaca’s gain, Isracard consolidation, and strong North Sea results.DLEKG
Q3 2025 - Revenues and EBITDAX climbed, but net income fell amid acquisitions and security disruptions.DLEKG
Q2 2025 - H1 2024 net income dropped to NIS 651m, with Israeli gas growth offset by North Sea declines.DLEKG
Q2 2024 - Q3 2024 net income was ₪403m, with strong Leviathan sales and ongoing dividends.DLEKG
Q3 2024 - Net income reached NIS 1.4B, with strong dividends and portfolio diversification underway.DLEKG
Q4 2024 - Revenue, EBITDAX, and adjusted net income surged, supported by strong operations and capital discipline.DLEKG
Q1 2025